Mother-Child Relations study: Maxxine Wright Program
Official title Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright
ClinicalTrials.gov ID: NCT05768815
What this study is testing
- What it's testing
- The study wants to find out if the Breaking the Cycle program, which includes infant mental health support, leads to better mental health for babies and better outcomes for mothers compared to the Maxxine Wright program that focuses mainly on mothers.
- Who it's for
- It is looking for mothers who use substances and have infants, and their children.
- What's involved
- Participants will receive either the BTC or MW program and fill out questionnaires at the start, 12 months later, and 24 months later. The questionnaires ask about stress, depression, parenting, and the home environment.
- Time commitment
- The study lasts about two years, with three questionnaire visits: at the beginning, one year after starting the program, and two years after starting the program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- receiving services at either BTC or MW
- having a child under the age of 6 years
- being able to answer a questionnaire in English
The study team makes the final eligibility decision.
Where it is enrolling
- Surrey, British Columbia, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Surrey, British Columbia, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.